Diabetes Board decisions

The VA determined that the Veteran's coronary artery disease was not caused by his military service, including exposure to Agent Orange. The Board found no evidence of a direct link between the Veteran's service-connected diabetes and his coronary artery disease.

The Board has remanded the case due to incomplete deck logs for the USS NEW JERSEY, which were requested in prior remands. The Veteran's claim for service connection for diabetes mellitus is being returned to the RO for further development.

The Veteran's claims for service connection for diabetes mellitus, type II, a right foot disorder, and a left foot disorder are being remanded due to the need for additional development.

The appellant's claims have been dismissed due to his death, and no longer have jurisdiction.

The Veteran's service-connected type II diabetes mellitus disability is currently rated at 40 percent, which more nearly approximates the criteria for a rating of 40 percent based on symptoms requiring insulin and regulation of activities.

The Board has determined that the Veteran's claims for service connection for various conditions, including diabetes mellitus, type II and eczema (claimed as rash/itching), are denied due to lack of evidence linking these conditions to his active service or herbicide exposure.

The Veteran's claims for increased ratings for diabetes mellitus, type II and left ear tympanic membrane perforation have been denied as the evidence does not show that his conditions are more severe than currently evaluated.

The Board has determined that the Veteran's heart disorder, hypertension, and diabetes mellitus, type II are not related to service. The appeal for these conditions is denied.

The Veteran's claims for increased ratings and TDIU are being remanded due to inadequate examinations, need for further development of his employment status, and the inextricability of these issues.

The Board has determined that the Veteran's service in Vietnam qualifies him for presumptive service connection for diabetes mellitus type II due to exposure to Agent Orange. As a result, the claim is granted.

The case is being remanded for additional development of the Veteran's claims, including obtaining complete VA treatment records and providing the Veteran with appropriate examinations to determine the etiology of his conditions.

The Veteran's diabetes mellitus has been rated at 20 percent, which is the maximum rating available under current criteria. The Board found that his diabetes requires insulin and a restricted diet but not regulation of activities.

The Veteran's diabetes mellitus type-II was service connected effective August 15, 2005.

The Veteran's claim for service connection for hypertension is being remanded due to the need for a new VA examination and consideration of his diabetes mellitus.

The Veteran's claim for an increased evaluation of 20 percent for diabetes mellitus, type II with erectile dysfunction was denied as the veteran failed to report for scheduled VA examinations without good cause.

The Veteran's nonservice-connected disabilities do not meet the criteria for special monthly pension based on need for regular aid and attendance or by reason of being housebound.

The Veteran seeks service connection for hypertension as secondary to his service-connected diabetes mellitus, type II. The Board finds that additional development is needed before rendering a decision on this matter.

The Veteran's appeal was denied for various conditions, with the exception of reopening a claim for residuals of infectious hepatitis. The initial rating for diabetes mellitus type II remains at 20 percent.

The Veteran seeks eligibility for Class III dental treatment and reimbursement of dental expenses related to the removal of unspecified teeth due to diabetes mellitus. The case is being remanded for further development.

The Board has determined that the Veteran's service-connected peptic ulcer disease contributed to his fatal small bowel cancer, and therefore grants service connection for the cause of death.